Accelerate hit identification with a target-specific screening set, custom-tailored for your drug discovery project! Our custom targeted library design service provides a ready-to-screen, structure-driven compound set, optimized for early drug discovery programs and cost-conscious research environments.
High-value library design at a fixed, transparent price
- 960 screening compounds supplied in 96-well plates (≈ 2 µmol solid per compound)
- Compound selection from our in-stock proprietary HTS Compound Collection of 600,000 drug-like molecules
- Structure-based virtual screening (molecular docking) against your protein target (PDB structure or validated homology model)
- Chemotype clustering and diversity filtering to maximize chemical space coverage
- Complete data package, including docking scores, 3D binding poses, and selection rationale
- Fast turnaround: typically 3–4 weeks from purchase order to compound shipment
- Custom compound selections and alternative library sizes available on request
How to order
Contact our Customer Service team at marketing@lifechemicals.com, quote promo code #Custom960, and specify your target and any relevant project details.
Designed for early drug discovery
This service supports hit identification and early lead generation across a broad range of biological targets, including GPCRs, kinases, proteases and other validated or emerging therapeutic targets. It is an efficient and cost-effective solution for first-in-class projects, exploratory screening campaigns, and proof-of-concept studies.
Academic-friendly and flexible
Fully compatible with the Life Chemicals Academic Support Program, this offer is particularly well-suited for academic researchers, translational groups, and collaborative consortia, including projects funded under Horizon Europe Research and Innovation Actions (RIA), Innovation Actions (IA), and similar national or EU funding schemes.
Optional add-on: enhance hit quality
Further refine your library using a pharmacophore-based model, derived from known ligands or key binding-site features. This optional enhancement helps preserve critical interactions and increase the probability of hit finding (availability depends on the target and data).
Disclaimer
References to Horizon Europe, Innovative Health Initiative, European Innovation Council, or other EU research programs are provided for informational purposes only and do not imply participation in, endorsement by, or funding from the European Union or its agencies.